SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-004274
Filing Date
2023-01-20
Accepted
2023-01-20 16:31:07
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4131
  Complete submission text file 0001209191-23-004274.txt   5502
Mailing Address 1301 SECOND AVE., SUITE 4200 SEATTLE WA 98101
Business Address
LASEZKAY GEORGE M (Reporting) CIK: 0001020514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 23541434

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations